Ex-Vivo Maintenance of Primary Acute Myeloid Leukemia Cells

被引：0
|
作者：
Wen, Kwun Wah
Liu, Xiao-Lei
Dos Santos, Cedric
Huang, Jian
Carroll, Martin
Danet-Desnoyers, Gwenn
Klein, Peter
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Temple Univ, Philadelphia, PA 19122 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1535
引用
收藏
页码：386A / 386A
页数：1
相关论文
共 50 条
  • [21] Maintenance Therapy in Acute Myeloid Leukemia
    Sabakhtarishvili, Giorgi
    Ansari, Amir
    Tabbara, Imad A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (01): : 38 - 43
  • [22] Maintenance for acute myeloid leukemia revisited
    Büchner T.
    Krug U.
    Berdel W.E.
    Heinecke A.
    Sauerland M.C.
    Wörmann B.
    Hiddemann W.
    Current Treatment Options in Oncology, 2007, 8 (4) : 296 - 304
  • [23] Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells
    Patel, Sweta B.
    Kuznetsova, Valeriya
    Matkins, Victoria R.
    Franceski, Alana M.
    Bassal, Mahmoud A.
    Welner, Robert S.
    EXPERIMENTAL HEMATOLOGY, 2022, 115 : 1 - 13
  • [24] Thrombin Generation Is Differentially Affected By Anticoagulants in Patients with Acute Lymphoblastic Leukemia - an Ex-Vivo Study
    Leader, Avi
    Elitzur, Sarah
    Gavrieli, Baruch
    Spronk, Henri M. H.
    Nagy, Magdolna
    Van Oerle, Rene
    Spectre, Galia
    Shimony, Shai
    Moshe, Yakir
    Mahajna, Roaya
    Gilad, Gil
    Avrahami, Galia
    Izraeli, Shai
    Raanani, Pia
    Barzilai-Birenboim, Shlomit
    Wolach, Ofir
    BLOOD, 2022, 140 : 1252 - 1254
  • [25] An Ex-Vivo Combination Drug Sensitivity Platform for Predicting Sensitivity to FLT3 Inhibitor-Based Combination in Acute Myeloid Leukemia
    Sahib, Noor Rashidha Binte Meera
    Ying, Jen Wei
    Ooi, Melissa
    Chee, Yen Lin
    Rashid, Masturah
    Jayalakshmi, Jayalakshmi
    Chow, Edward K. H.
    BLOOD, 2022, 140 : 7840 - 7841
  • [26] Exome-wide association study reveals 7 functional variants associated with ex-vivo drug response in acute myeloid leukemia patients
    Giri, Anil K.
    Lin, Jake
    Kyriakidis, Konstantinos
    Tripathi, Garima
    Almusa, Henrikki
    BMC MEDICAL GENOMICS, 2025, 18 (01)
  • [27] AN EX-VIVO COMBINATION DRUG SENSITIVITY PLATFORM FOR PREDICTING SENSITIVITY TO FLT3 INHIBITOR-BASED COMBINATION IN ACUTE MYELOID LEUKEMIA
    Sahib, Noor Rashidha Bte Meera
    Ying, Jen Wei
    Ooi, Melissa
    Chee, Yen Lin
    Jayalakshmi
    Mohamed, Jameelah Bte Sheik
    Rashid, Masturah
    Chow, Edward K. H.
    CANCER RESEARCH, 2024, 84 (08)
  • [28] Large Scale Ex Vivo Expansion of Γδ T Cells Using Artificial Antigen Presenting Cells for the Treatment of Acute Myeloid Leukemia
    Boucher, Justin C.
    Yu, Bin
    Li, Gongbo
    Shrestha, Bishwas
    Lancet, Jeffrey E.
    Sallman, David A.
    Landin, Ana Marie
    Mailloux, Adam William
    Anasetti, Claudio
    Kelley, Linda L.
    Davila, Marco L.
    Bejanyan, Nelli
    BLOOD, 2020, 136
  • [29] Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells
    Rowland, Lauren
    Smart, Brandon
    Brown, Anthony
    Dettorre, Gino M.
    Gocho, Yoshihiro
    Hunt, Jeremy
    Yang, Wenjian
    Yoshimura, Satoshi
    Reyes, Noemi
    Du, Guoqing
    John, August
    Maxwell, Dylan
    Stock, Wendy
    Kornblau, Steven
    Relling, Mary, V
    Inaba, Hiroto
    Pui, Ching -Hon
    Bourquin, Jean-Pierre
    Karol, Seth E.
    Mullighan, Charles G.
    Evans, William E.
    Yang, Jun J.
    Crews, Kristine R.
    BIO-PROTOCOL, 2023, 13 (15):
  • [30] THE ROLE OF OSTEOBLASTS AND COLLAGEN FIBRIL NETWORK PROPERTIES IN THE EX-VIVO MAINTENANCE OF HEMATOPOIETIC PROGENITOR CELLS
    Chitteti, B. R.
    Brandner, E.
    Kuske, J.
    Kacena, M.
    Srour, E. F.
    Voytik-Harbin, S.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S22 - S23
12345